HPV vaccine acceptance among Latina mothers by HPV status

Journal of Women's Health

Volumn 18, Issue 11, 2009, Pages 1793-1799

  Sanderson, Maureen ^a   Coker, Ann L ^b   Eggleston, Katherine S ^b   Fernandez, Maria E ^c   Arrastia, Concepcion D ^d   Fadden, Mary K ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; DYSPLASIA; FEMALE; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; LAW; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MARRIAGE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VACCINATION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; CHILD; CHILD WELFARE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; MOTHER-CHILD RELATIONS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; TEXAS; UTERINE CERVICAL NEOPLASMS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 71449125765     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.1266     Document Type: Article

References (27)

1. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
2. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. Engl J Med 2002;347:1645-1651.
3. Paavonen J, Jenkins D, Bosch FX, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: An interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007;369: 2161-2170.
4. Ries LAG, Melbert D, Krapcho M, et al., eds. SEER cancer statistics review, 1975-2005. Bethesda, MD: National Cancer Institute, 2008.
5. Texas Cancer Registry. Cancer Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin, Texas. Available at www.dshs.state.tx.us=tcr= default.shtm or (512) 458-7523.
6. Giuliano AR, Papenfuss M, Schneider A, et al. Risk factors for high-risk type human papillomavirus infection among Mexican-American women. Cancer Epidemiol Biomarkers Prev 1999;8:615-620.
7. Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV. Pediatrics 2006;117:1486-1493.
8. Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15- year-old adolescents. J Low Genit Tract Dis 2004;8:188-194.
9. Gerend MA, Lee SC, Shepherd JE. Predictors of human papillomavirus vaccination acceptability among underserved women. Sex Transm Dis 2007;34:468-471.
10. Mays RM, Sturm LA, Zimet GD. Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med 2004;58:1405-1413.
11. Slomovitz BM, Sun CC, Frumovitz M, et al. Are women ready for the HPV vaccine? Gynecol Oncol 2006;103:151-154.
12. Hopenhayn C, Christian A, Christian WJ, Schoenberg NE. Human papillomavirus vaccine: Knowledge and attitudes in two Appalachian Kentucky counties. Cancer Causes Control 2007;18:627-634.
13. Marlow LA, Waller J, Wardle J. Parental attitudes to prepubertal HPV vaccination. Vaccine 2007;25:1945-1952.
14. Sauvageau C, Duval B, Gilca V, Lavoie F, Ouakki M. Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada. BMC Public Health 2007;7:304.
15. Dinh TA, Rosenthal SL, Doan ED, et al. Attitudes of mothers in Da Nang, Vietnam, toward a human papillomavirus vaccine. J Adolesc Health 2007;40:559-563.
16. Sperber NR, Brewer NT, Smith JS. Influence of parent characteristics and disease outcome framing on HPV vaccine acceptability among rural, Southern women. Cancer Causes Control 2008;19:115-118.
17. Lazcano-Ponce E, Rivera L, Arillo-Santillan E, Salmeron J, Hernandez-Avila M, Munoz N. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res 2001;32:243-247.
18. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: A representative statewide analysis. J Adolesc Health 2007;40:108-115.
19. Scarinci IC, Garces-Palacio IC, Partridge EE. An examination of acceptability of HPV vaccination among African American women and Latina immigrants. J Womens Health 2007; 16:1224-1233.
20. Becker MH, ed. The Health Belief Model and personal health behavior. Health Educ Monogr 1974;2:324-473.
21. Glanz K, Rimer BK, Lewis FM. Health behavior and health education. Theory, research and practice. San Fransisco: Wiley & Sons, 2002.
22. Fazekas KI, Brewer NT, Smith JS. HPV vaccine acceptability in a rural Southern area. J Womens Health 2008;17:539-548.
23. Olshen E, Woods ER, Austin SB, Luskin M, Bauchner H. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 2005;37:248-251.
24. Zimet GD, Mays RM, Sturm LA, Ravert AA, Perkins SM, Juliar BE. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med 2005;159:132-137.
25. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Prev Med 2007;45:107-114.
26. Adams M, Jasani B, Fiander A. Human papillomavirus (HPV) prophylactic vaccination: Challenges for public health and implications for screening. Vaccine 2007;25:3007-3013.
27. Kulasingam SL, Pagliusi S, Myers E. Potential effects of decreased cervical cancer screening participation after HPV vaccination: An example from the U.S. Vaccine 2007;25: 8110-8113.